Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
出版年份 2016 全文链接
标题
Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
作者
关键词
Cancer stem cell, Drug resistance, Nanotechnology, Gene therapy, Immunotherapy, Review
出版物
TUMOR BIOLOGY
Volume 37, Issue 10, Pages 13059-13075
出版商
Springer Nature
发表日期
2016-08-26
DOI
10.1007/s13277-016-5294-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway
- (2015) Hyunsook An et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery
- (2015) Jijin Gu et al. BIOMATERIALS
- DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
- (2015) Olga Grishina et al. BMC CANCER
- Nanobiotechnological Approaches to Overcome Drug Resistance in Breast Cancer
- (2015) Peyman Ranji et al. CURRENT CANCER DRUG TARGETS
- Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15
- (2015) Vita Golubovskaya et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts
- (2015) Yinan Zhong et al. JOURNAL OF CONTROLLED RELEASE
- Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells
- (2015) Mohammad Johari-Ahar et al. JOURNAL OF DRUG TARGETING
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Mitochondrial targeted peptides for cancer therapy
- (2015) Sadaf Farsinejad et al. TUMOR BIOLOGY
- Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model
- (2015) Cuiping Yang et al. Oncotarget
- The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma
- (2015) Andrea Di Cristofori et al. Oncotarget
- MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
- (2015) Xiaoqian Yang et al. Scientific Reports
- EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
- (2015) Tao Wang et al. Theranostics
- The Role of CD44 in Disease Pathophysiology and Targeted Treatment
- (2015) Andre R. Jordan et al. Frontiers in Immunology
- EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
- (2015) Nithya Subramanian et al. PLoS One
- Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status
- (2015) Zhiguang Xiao et al. Oncotarget
- Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features
- (2015) Elina Jokinen et al. Oncotarget
- Selective inhibition of breast cancer stem cells by gold nanorods mediated plasmonic hyperthermia
- (2014) Yingying Xu et al. BIOMATERIALS
- A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth
- (2014) Maria B Lebron et al. CANCER BIOLOGY & THERAPY
- Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
- (2014) Neng Wang et al. CARCINOGENESIS
- Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
- (2014) Mohammad Hojjat-Farsangi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Folate and CD44 Receptors Dual-Targeting Hydrophobized Hyaluronic Acid Paclitaxel-Loaded Polymeric Micelles for Overcoming Multidrug Resistance and Improving Tumor Distribution
- (2014) Yanhua Liu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The novel EpCAM-targeting monoclonal antibody 3–17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines
- (2014) Kaja Lund et al. mAbs
- MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance
- (2014) Richard Ottman et al. Molecular Cancer
- Targeting MET for glioma therapy
- (2014) Ahmed J. Awad et al. Neurosurgical Focus
- Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation
- (2014) O Shimozato et al. ONCOGENE
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like Cells
- (2014) Prakash Rath et al. Translational Oncology
- Metastasis review: from bench to bedside
- (2014) Ali Mohammad Alizadeh et al. TUMOR BIOLOGY
- An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity
- (2014) U Krause et al. Cell Death & Disease
- EpCAM proteolysis: new fragments with distinct functions?
- (2013) Ulrike Schnell et al. BIOSCIENCE REPORTS
- The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents
- (2013) C. Dos Santos et al. BLOOD
- Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists
- (2013) Kenneth K W To et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy
- (2013) Manuel Simon et al. Expert Opinion on Drug Delivery
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- A new gamboge derivative Compound 2 inhibits cancer stem-like cellsviasuppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma
- (2013) Rongxin Deng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tunicamycin Potentiates Cisplatin Anticancer Efficacy through the DPAGT1/Akt/ABCG2 Pathway in Mouse Xenograft Models of Human Hepatocellular Carcinoma
- (2013) H. Hou et al. MOLECULAR CANCER THERAPEUTICS
- Nanofiber-mediated inhibition of focal adhesion kinase sensitizes glioma stemlike cells to epidermal growth factor receptor inhibition
- (2013) Maya Srikanth et al. NEURO-ONCOLOGY
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
- (2013) Y. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation
- (2013) Gérald Bertrand et al. Stem Cell Reviews and Reports
- Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells—an in vitro and in silico study
- (2013) Santhi Latha Pandrangi et al. TUMOR BIOLOGY
- Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer
- (2012) Chi-Tai Yeh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
- (2012) Makoto Kubo et al. BREAST CANCER RESEARCH AND TREATMENT
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors
- (2012) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
- Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells
- (2012) Ji-Young Jang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
- (2012) Hans-Joachim Schmoll et al. JOURNAL OF CLINICAL ONCOLOGY
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib
- (2012) Y. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cells and drug resistance: the potential of nanomedicine
- (2012) Serguei Vinogradov et al. Nanomedicine
- Aptamers and Their Biological Applications
- (2012) Kyung-Mi Song et al. SENSORS
- Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches
- (2012) Cristóbal Aguilar-Gallardo et al. Stem Cell Reviews and Reports
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
- (2012) Xue Xue et al. Chinese Journal of Cancer
- Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery
- (2012) Timothy E. Andrews et al. Drug Delivery and Translational Research
- Cancer stem cells and therapeutic targets: an emerging field for cancer treatment
- (2012) Arokia Priyanka Vaz et al. Drug Delivery and Translational Research
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line
- (2011) Jun Dou et al. CELL BIOLOGY INTERNATIONAL
- Targeting the Multidrug ABCG2 Transporter with Flavonoidic Inhibitors: In Vitro Optimization and In Vivo Validation
- (2011) A. Boumendjel et al. CURRENT MEDICINAL CHEMISTRY
- Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?
- (2011) Angela Alama et al. DRUG DISCOVERY TODAY
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells
- (2011) Celia Chao et al. LABORATORY INVESTIGATION
- Sustained Expression of the RON Receptor Tyrosine Kinase by Pancreatic Cancer Stem Cells as a Potential Targeting Moiety for Antibody-Directed Chemotherapeutics
- (2011) Snehal S. Padhye et al. MOLECULAR PHARMACEUTICS
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
- (2011) L Y W Bourguignon et al. ONCOGENE
- ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma
- (2011) R R Singh et al. ONCOGENE
- Inhibition of Ataxia Telangiectasia- and Rad3 -Related Function Abrogates the In Vitro and In Vivo Tumorigenicity of Human Colon Cancer Cells Through Depletion of the CD133+ Tumor-Initiating Cell Fraction
- (2011) Eike Gallmeier et al. STEM CELLS
- Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells
- (2010) Ji-Young Jang et al. BMC CANCER
- Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
- (2010) Markus Münz et al. Cancer Cell International
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- The cancer stem cell paradigm: a new understanding of tumor development and treatment
- (2010) Johnathan D Ebben et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells
- (2010) Tung-Ying Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sunitinib Malate and Figitumumab in Solitary Fibrous Tumor: Patterns and Molecular Bases of Tumor Response
- (2010) S. Stacchiotti et al. MOLECULAR CANCER THERAPEUTICS
- The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
- (2010) Irene Ma et al. Stem Cell Reviews and Reports
- A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
- (2009) Brian Thiessen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
- (2009) E. Bolderson et al. CLINICAL CANCER RESEARCH
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
- (2009) Sung Pil Hong et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
- (2009) Alexei V. Salnikov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-Cell lymphoma
- (2009) Ji Eun Kim et al. MODERN PATHOLOGY
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Human aldehyde dehydrogenase genes: alternatively spliced transcriptional variants and their suggested nomenclature
- (2009) William J. Black et al. Pharmacogenetics and Genomics
- A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer Chemotherapy
- (2009) Hui Peng et al. PLoS One
- Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
- (2008) Satori A Marchitti et al. Expert Opinion on Drug Metabolism & Toxicology
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation